These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3021926)
21. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors. Souness JE; Hassall GA; Parrott DP Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964 [TBL] [Abstract][Full Text] [Related]
22. Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices. Schoffelmeer AN; Wierenga EA; Mulder AH J Neurochem; 1986 Jun; 46(6):1711-7. PubMed ID: 2422322 [TBL] [Abstract][Full Text] [Related]
23. Forskolin modulates acetylcholine release in the hippocampus independently of adenylate cyclase activation. Allgaier C; Choi BK; Hertting G Eur J Pharmacol; 1990 Jun; 181(3):279-82. PubMed ID: 2384134 [TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP or forskolin rapidly attenuates the depressant effects of opioids on sensory-evoked dorsal-horn responses in mouse spinal cord-ganglion explants. Crain SM; Crain B; Peterson ER Brain Res; 1986 Apr; 370(1):61-72. PubMed ID: 3011195 [TBL] [Abstract][Full Text] [Related]
26. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes. Nicholson D; White TD; Sawynok J Can J Physiol Pharmacol; 1991 Jun; 69(6):877-85. PubMed ID: 1717120 [TBL] [Abstract][Full Text] [Related]
27. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Kumari M; Cover PO; Poyser RH; Buckingham JC Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of histamine-stimulated inositol phospholipid hydrolysis by agents which increase cyclic AMP levels in bovine tracheal smooth muscle. Hall IP; Donaldson J; Hill SJ Br J Pharmacol; 1989 Jun; 97(2):603-13. PubMed ID: 2547479 [TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583 [TBL] [Abstract][Full Text] [Related]
31. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor. Barnard JW; Seibert AF; Prasad VR; Smart DA; Strada SJ; Taylor AE; Thompson WJ J Appl Physiol (1985); 1994 Aug; 77(2):774-81. PubMed ID: 8002527 [TBL] [Abstract][Full Text] [Related]
32. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein. Wright IK; Amirchetty-Rao S; Kendall DA Br J Pharmacol; 1994 Aug; 112(4):1146-50. PubMed ID: 7524992 [TBL] [Abstract][Full Text] [Related]
33. Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs. Germain N; Bertin B; Legendre A; Martin B; Lagente V; Payne A; Boichot E Eur Respir J; 1998 Dec; 12(6):1334-9. PubMed ID: 9877487 [TBL] [Abstract][Full Text] [Related]
34. Spinal vs. supraspinal sites of action of the alpha 2-adrenergic agonists clonidine and ST-91 on the acoustic startle reflex. Davis M; Commissaris RL; Yang S; Wagner KR; Kehne JH; Cassella JV; Boulis NM Pharmacol Biochem Behav; 1989 May; 33(1):233-40. PubMed ID: 2571168 [TBL] [Abstract][Full Text] [Related]
35. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action. Commissaris RL; Davis M Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat. Correa-Sales C; Nacif-Coelho C; Reid K; Maze M J Pharmacol Exp Ther; 1992 Dec; 263(3):1046-9. PubMed ID: 1361568 [TBL] [Abstract][Full Text] [Related]
37. Differential blockade of early and late components of acoustic startle following intrathecal infusion of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or D,L-2-amino-5-phosphonovaleric acid (AP-5). Boulis NM; Kehne JH; Miserendino MJ; Davis M Brain Res; 1990 Jun; 520(1-2):240-6. PubMed ID: 1976408 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of forskolin and dibutyryl cyclic AMP in neuroblastoma cells: evidence that some of the actions of dibutyryl cyclic AMP are mediated by butyrate. Yusta B; Ortiz-Caro J; Pascual A; Aranda A J Neurochem; 1988 Dec; 51(6):1808-18. PubMed ID: 2846786 [TBL] [Abstract][Full Text] [Related]
39. Role of cAMP for regulation of impulse-evoked noradrenaline release from the rabbit pulmonary artery and its possible relationship to presynaptic ACTH receptors. Göthert M; Hentrich F Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):127-34. PubMed ID: 6098833 [TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. Liang KC; Melia KR; Miserendino MJ; Falls WA; Campeau S; Davis M J Neurosci; 1992 Jun; 12(6):2303-12. PubMed ID: 1351540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]